Sourse: Business Standard
The Indian pharma sector is turning its attention to diabetes, arthritis and other diseases of the developed world.

India is projected to break into the ranks of middle-income countries by the end of the current financial year. Before that can happen, Indian pharmaceutical companies have re-oriented their research and development priorities from infectious diseases found in the under-developed world to chronic lifestyle disorders that threaten the developed world.

Read More....